IMMU-12. IMMUNOTHERAPY OF WILMS TUMOR 1 PEPTIDE VACCINATION IMPROVE PROGNOSIS OF RECURRENT GLIOBLASTOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA IN CHILDREN

BACKGROUND: We have ever proven safety and effectiveness of Wilms tumor 1 peptide (WT1) vaccination for newly-diagnosed or recurrent glioblastomas (GBM) in adult. But pediatric GBM and diffuse intrinsic pontine glioma (DIPG) are known to differ from adult GBM biologically. A pilot study designed to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Kagawa, Naoki, Hashii, Yoshiko, Hirayama, Ryuichi, Chiba, Yasuyoshi, Arita, Hideyuki, Yokota, Chisato, Achiha, Takamune, Kijima, Noriyuki, Fujimoto, Yasunori, Hashimoto, Naoya, Sugiyama, Haruo, Yoshimine, Toshiki
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475090/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.122
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares